Laura C. Kendall - 30 Jul 2026 Form 4 Insider Report for HomeTrust Bancshares, Inc. (HTB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Aug 2026, 10:02:18 UTC
Prior SEC filing
03 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tony J. VunCannon, Attorney-in-Fact for Laura C. Kendall

Key filing fact

Laura C. Kendall filed Form 4 for HomeTrust Bancshares, Inc. (HTB) on 03 Aug 2026.

Key facts

  • This page summarizes Laura C. Kendall's Form 4 filing for HomeTrust Bancshares, Inc. (HTB).
  • 3 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 03 Aug 2026, 10:02.

Change

  • Previous filing in this sequence was filed on 03 Jun 2026.
  • Current net transaction value: -$511,348.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001236809 Primary reporting owner

KENDALL LAURA C

Relationship
Director
Address
C/O HOMETRUST BANCSHARES, INC., 10 WOODFIN STREET, ASHEVILLE
Signature
/s/ Tony J. VunCannon, Attorney-in-Fact for Laura C. Kendall
Signature date
03 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HTB transaction

Common Stock

Options Exercise

Transaction value
Shares
+10,000
Change %
+41%
Price
$24.95*
Shares after
34,229
Date
30 Jul 2026
Ownership
Direct
HTB transaction

Common Stock

Sale

Transaction value
$511,348
Shares
-10,000
Change %
-29%
Price
$51.13
Shares after
24,229
Date
30 Jul 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HTB transaction Derivative

Stock Option

Options Exercise

Transaction value
Shares
-10,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
30 Jul 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$24.95
Footnotes
F4
HTB holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,000
Date
30 Jul 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,000
Exercise price
$27.51
Footnotes
F2
HTB holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,000
Date
30 Jul 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,000
Exercise price
$26.00
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.92 to $51.695, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F2

Represents stock option granted under Issuer's 2013 Omnibus Incentive Plan with the following vesting schedule: 100% on February 11, 2020.

Footnote F3

Represents stock option granted under Issuer's 2013 Omnibus Incentive Plan with the following vesting schedule: 100% on February 11, 2019.

Footnote F4

Represents stock option granted under Issuer's 2013 Omnibus Incentive Plan with the following vesting schedule: 20% increments on February 11, 2018, 2019, 2020, 2021 and 2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .